We recently published 10 Stocks Left Behind Amid Wall Street Cheer. Perrigo Company plc (NYSE:PRGO) is one of the ...

Despite the earnings beat, Perrigo lowered its full-year 2025 outlook, now expecting adjusted earnings of $2.70 to $2.80 per share, below the previous analyst consensus of $2.98. The company also ...

Net sales show the true revenue your business makes from selling products or services, after subtracting returns, allowances and discounts. To find net sales, begin with your total sales and deduct ...

Formulas for toddlers are a burgeoning business in the United States: Sales of the drinks more than doubled in recent years as companies convinced parents that their little ones needed the liquid ...

Perrigo (PRGO) on Wednesday said that it is initiating a strategic review of its infant formula business, which will assess a ...

Q3 2025 Management View CEO Patrick Lockwood-Taylor reported that "Perrigo has delivered sustained share gains and advanced key initiatives under our Three-S plan to Stabilize, Streamline and to ...

Perrigo PRGO reported adjusted earnings of 80 cents per share in the third quarter of 2025, beating the Zacks Consensus Estimate of 75 cents. The reported figure fell 1.2% year over year ...

A baby formula shortage fueled by supply chain issues and recalls is getting worse: Now, major retailers are limiting formula sales in response to high demand. According to an analysis done by ...

Quarterly Net Profit at Rs. 0.82 crore in September 2025 up 839.42% from Rs. 0.11 crore in September 2024. EBITDA stands at ...

Chinese infant nutrition firm Synutra International has been able to capitalise on the Beijing’s production licence initiative, picking up distribution where other companies fail to gain a permit.